FETAL METHYLATION MARKERS
    24.
    发明申请
    FETAL METHYLATION MARKERS 有权
    方法甲基标记

    公开(公告)号:US20130084566A1

    公开(公告)日:2013-04-04

    申请号:US13618527

    申请日:2012-09-14

    Abstract: This application describes the discovery that, in a pregnant woman, certain genes (such as RASSF1A, APC, CASP8, RARB, SCGB3A1, DAB2IP, PTPN6, THY1, TMEFF2, and PYCARD) originated from a fetus are highly methylated, whereas the same genes of maternal origin are unmethylated. This discovery allows the easy detection of one or more of these methylated fetal genes in a biological sample from a pregnant woman, serving as a universal indicator of the presence of fetal DNA in the sample. These fetal methylation markers are particularly useful as positive controls for a non-invasive analytical process during which the quality and quantity of fetal DNA are monitored. These newly identified fetal markers can also be measured directly for diagnosis of certain pregnancy-related conditions.

    Abstract translation: 该应用描述了在孕妇中发现来自胎儿的某些基因(如RASSF1A,APC,CASP8,RARB,SCGB3A1,DAB2IP,PTPN6,THY1,TMEFF2和PYCARD)高度甲基化,而相同的基因 产妇来源是未甲基化。 该发现允许从孕妇的生物样品中容易地检测这些甲基化胎儿基因中的一种或多种,​​作为样品中胎儿DNA存在的通用指标。 这些胎儿甲基化标记物作为非侵入性分析过程的阳性对照特别有用,在此过程中监测胎儿DNA的质量和数量。 这些新确定的胎儿标记物也可以直接测量以诊断某些妊娠相关病症。

    NEW FETAL METHYLATION MARKERS
    25.
    发明申请
    NEW FETAL METHYLATION MARKERS 有权
    新型甲基化标记

    公开(公告)号:US20110143342A1

    公开(公告)日:2011-06-16

    申请号:US12791776

    申请日:2010-06-01

    Abstract: This application describes the discovery that, in a pregnant woman, certain genes (such as RASSF1A, APC, CASP8, RARB, SCGB3A1, DAB2IP, PTPN6, THY1, TMEFF2, and PYCARD) originated from a fetus are highly methylated, whereas the same genes of maternal origin are unmethylated. This discovery allows the easy detection of one or more of these methylated fetal genes in a biological sample from a pregnant woman, serving as a universal indicator of the presence of fetal DNA in the sample. These fetal methylation markers are particularly useful as positive controls for a non-invasive analytical process during which the quality and quantity of fetal DNA are monitored. These newly identified fetal markers can also be measured directly for diagnosis of certain pregnancy-related conditions.

    Abstract translation: 该应用描述了在孕妇中发现来自胎儿的某些基因(如RASSF1A,APC,CASP8,RARB,SCGB3A1,DAB2IP,PTPN6,THY1,TMEFF2和PYCARD)高度甲基化,而相同的基因 产妇来源是未甲基化。 该发现允许从孕妇的生物样品中容易地检测这些甲基化胎儿基因中的一种或多种,​​作为样品中胎儿DNA存在的通用指标。 这些胎儿甲基化标记物作为非侵入性分析过程的阳性对照特别有用,在此过程中监测胎儿DNA的质量和数量。 这些新确定的胎儿标记物也可以直接测量以诊断某些妊娠相关病症。

    Fetal methylation markers
    27.
    发明授权
    Fetal methylation markers 有权
    胎儿甲基化标记

    公开(公告)号:US07754428B2

    公开(公告)日:2010-07-13

    申请号:US11784501

    申请日:2007-04-06

    Abstract: This application describes the discovery that, in a pregnant woman, certain genes (such as RASSF1A, APC, CASP8, RARB, SCGB3A1, DAB2IP, PTPN6, THY1, TMEFF2, and PYCARD) originated from a fetus are highly methylated, whereas the same genes of maternal origin are unmethylated. This discovery allows the easy detection of one or more of these methylated fetal genes in a biological sample from a pregnant woman, serving as a universal indicator of the presence of fetal DNA in the sample. These fetal methylation markers are particularly useful as positive controls for a non-invasive analytical process during which the quality and quantity of fetal DNA are monitored. These newly identified fetal markers can also be measured directly for diagnosis of certain pregnancy-related conditions.

    Abstract translation: 该应用描述了在孕妇中发现来自胎儿的某些基因(如RASSF1A,APC,CASP8,RARB,SCGB3A1,DAB2IP,PTPN6,THY1,TMEFF2和PYCARD)高度甲基化,而相同的基因 产妇来源是未甲基化。 该发现允许从孕妇的生物样品中容易地检测这些甲基化胎儿基因中的一种或多种,​​作为样品中胎儿DNA存在的通用指标。 这些胎儿甲基化标记物作为非侵入性分析过程的阳性对照特别有用,在此过程中监测胎儿DNA的质量和数量。 这些新确定的胎儿标记物也可以直接测量以诊断某些妊娠相关病症。

    Method for non-invasive prenatal diagnosis
    30.
    发明申请
    Method for non-invasive prenatal diagnosis 审中-公开
    非侵入性产前诊断方法

    公开(公告)号:US20070207466A1

    公开(公告)日:2007-09-06

    申请号:US11364294

    申请日:2006-02-28

    Abstract: The present invention is directed to methods of detecting nucleic acids in a biological sample. The method is based on a novel combination of a base extension reaction, which provides excellent analytical specificity, and a mass spectrometric analysis, which provides excellent specificity. The method can be used, for example, for diagnostic, prognostic and treatment purposes. The method allows accurate detection of nucleic acids that are present in very small amounts in a biological sample. For example, the method of the present invention is preferably used to detect fetal nucleic acid in a maternal blood sample; circulating tumor-specific nucleic acids in a blood, urine or stool sample; and donor-specific nucleic acids in transplant recipients. In another embodiment, one can detect viral, bacterial, fungal, or other foreign nucleic acids in a biological sample.

    Abstract translation: 本发明涉及检测生物样品中核酸的方法。 该方法基于提供优异分析特异性的碱基延伸反应和提供优异特异性的质谱分析的新型组合。 该方法可用于例如诊断,预后和治疗目的。 该方法允许精确检测在生物样品中以非常少的量存在的核酸。 例如,本发明的方法优选用于检测母体血液样品中的胎儿核酸; 在血液,尿液或粪便样品中循环肿瘤特异性核酸; 和供体特异性核酸。 在另一个实施方案中,可以检测生物样品中的病毒,细菌,真菌或其它外来核酸。

Patent Agency Ranking